YARW Yarrow Bioscience, Inc.
$20.00▲ +3.79%
Healthcare
Other
Volume 162.2K
Avg Volume (10D) 122.4K
Key Metrics & Fundamentals
Market Cap
$186.09M
P/E Ratio
–
Div Yield
0.00%
52W Range
16.05 - 46.95
% vs 50 MA
-26.54%
% vs 200 MA
-35.36%
RSI-14
40.4
MACD Histogram
+0.4800
Beta (1Y vs SPY)
0.22
Free Cash Flow
$67.57M
Gross Rev
$97,000
Gross Profit
$97,000
EBITDA
-$3.10M
COGS
–
Operating Exp
$3.20M
Operating Income
-$3.10M
EBIT
-$3.10M
Pretax Income
-$2.90M
Net Income
-$3.01M
EPS (Diluted)
-175.50
Price & Volume History
Loading chart…
Recent News
Yarrow Bioscience Closes $172.5 Million Public Offering
MT Newswires · Sep 14, 2026 4:46 PM ET
Yarrow Bioscience Announces Closing of its $172.5 Million Underwritten Public Offering Including Full Exercise of the Underwriters’ Option to Purchase Additional Shares
Business Wire · Sep 14, 2026 4:05 PM ET
Yarrow Bioscience Announces Pricing of $150 Million Underwritten Public Offering
Business Wire · Sep 10, 2026 9:11 PM ET
Yarrow Bioscience Launches Public Offering of Common Stock
MT Newswires · Sep 10, 2026 4:31 PM ET
Yarrow Bioscience Announces Proposed Underwritten Public Offering
Business Wire · Sep 10, 2026 4:03 PM ET
Yarrow Bioscience Reports Second Quarter 2026 Financial Results and Provides Business Update
Business Wire · Aug 13, 2026 7:00 AM ET
Financial Overview - Income Statement
Quarterly
Jun 2026
See YARW's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.